Next, we generated cell lines from lymphomas from Eμ-MycT/+;Bcl-w+/+, Eμ-MycT/+;Bcl-w+/−, and Eμ-MycT/+;Bcl-w−/− mice (n = 5 each) to examine whether MYC-driven lymphomas that had developed in the absence of BCL-W would respond differently to anti-cancer agents. The gene discussed is BCL2L2; the disease is lymphoma.